Department of Infectious Diseases, Institute of Biomedicine at the Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Addiction and Dependency, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden.
Sci Rep. 2022 Nov 17;12(1):19818. doi: 10.1038/s41598-022-24307-1.
This study aimed to examine current symptom severity and general health in a sample of primarily non-hospitalized persons with polymerase chain reaction (PCR) confirmed COVID-19 in comparison to PCR negative controls. During the first quarter of 2021, we conducted an online survey among public employees in West Sweden, with a valid COVID-19 test result. The survey assessed past-month severity of 28 symptoms and signs, self-rated health, the WHO Disability Assessment Schedule (WHODAS) 2.0 and illness severity at the time of test. We linked participants' responses to their SARS-CoV-2 PCR tests results. We compared COVID-19 positive and negative participants using univariable and multivariable regression analyses. Out of 56,221 invited, 14,222 (25.3%) responded, with a response rate of 50% among SARS-CoV-2 positive individuals. Analysis included 10,194 participants (86.4% women, mean age 45 years) who tested positive 4-12 weeks (N = 1425; subacute) and > 12 weeks (N = 1584; postcovid) prior to the survey, and 7185 PCR negative participants who did not believe that they had had COVID-19. Symptoms were highly prevalent in all groups, with worst symptoms in subacute phase participants, followed by postcovid phase and PCR negative participants. The most specific symptom for COVID-19 was loss of smell or taste. Both WHODAS 2.0 score and self-rated health were worst in subacute participants, and modestly worse in postcovid participants than in negative controls. Female gender, older age and acute illness severity had larger effects on self-rated health and WHODAS 2.0 score in PCR positive participants than in PCR negative. Studies with longer follow-up are needed to determine the long-term improvement after COVID-19.
本研究旨在比较聚合酶链反应(PCR)确诊的 COVID-19 患者和 PCR 阴性对照者的当前症状严重程度和总体健康状况。2021 年第一季度,我们在瑞典西部的公共部门员工中开展了一项在线调查,参与者提供了有效的 COVID-19 检测结果。该调查评估了过去一个月 28 种症状和体征的严重程度、自我评估的健康状况、世界卫生组织残疾评估表(WHODAS)2.0 和检测时的疾病严重程度。我们将参与者的回答与他们的 SARS-CoV-2 PCR 检测结果相关联。我们使用单变量和多变量回归分析比较了 COVID-19 阳性和阴性参与者。在邀请的 56221 人中,有 14222 人(25.3%)做出了回应,SARS-CoV-2 阳性个体的回应率为 50%。分析包括 10194 名参与者(86.4%为女性,平均年龄 45 岁),他们在调查前 4-12 周(N=1425;亚急性)和>12 周(N=1584;新冠后)检测出 SARS-CoV-2 阳性,以及 7185 名 PCR 阴性参与者,他们认为自己没有感染过 COVID-19。所有组的症状都高度普遍,亚急性组的症状最严重,其次是新冠后组和 PCR 阴性组。对 COVID-19 最特异的症状是嗅觉或味觉丧失。亚急性组的 WHODAS 2.0 评分和自我评估的健康状况最差,新冠后组比 PCR 阴性组稍差。在 PCR 阳性参与者中,女性、年龄较大和急性疾病严重程度对自我评估的健康状况和 WHODAS 2.0 评分的影响大于 PCR 阴性参与者。需要进行更长时间随访的研究来确定 COVID-19 后的长期改善情况。